Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

216 Press Releases
DateTitleCompany
07 Jul 14 Wyatt Technology’s DynaPro® Plate Reader Optimizes Screening Process for Biotherapeutic Candidates and Formulations Wyatt Technology
04 Jul 14 Healthcare Leaders to Chart Out Blueprint of Healthcare Reforms at India Leadership Conclave 2014 Network 7 Media Group
02 Jul 14 Synergy Vision’s Sorcha Ferris Tipped As Emerging Leader 2014 Synergy Vision
02 Jul 14 HELSINN GROUP AND GEN ILAÇ ESTABLISH A COLLABORATION FOR ANAMORELIN IN TURKEY Helsinn Group
02 Jul 14 REAL WORLD DATA TO BE PRESENTED FOR FYCOMPA® (PERAMPANEL) Eisai,
Published by
toniclc.com
02 Jul 14 PAREXEL INTERNATIONAL ANNOUNCES ACQUISITION OF ATLAS MEDICAL SERVICES, A PROVIDER OF CLINICAL RESEARCH SERVICES IN TURKEY Parexel,
Published by
PharmiWeb.com
30 Jun 14 Emerging Data From The FIRE-3 Study, Shows Potentially Significant Improvements in tumour response and shrinkage in the subset of patients with RAS... Merck Serono,
Published by
Reynolds-MacKenzie
30 Jun 14 Principal Investigators Launches the World’s First Place for Clinical Trial & Patient Referral Offers. Principalinvestigators.com,
Published by
www.principalinvestigators.com
27 Jun 14 Novella Clinical Names Dr. Lynne Bui Senior Medical Director of Oncology Division Novella Clinical
26 Jun 14 CPhI Istanbul cements rapid pharma sector growth in Eurasia, Central Asia and MENA regions UBM Live,
Published by
De Facto
25 Jun 14 Orgenesis Receives $1.5 Million Term Loan to Help Fund Breakthrough Innovation in Diabetes Research Orgenesis
25 Jun 14 Japanese stem cell research raises wider discussion on medical research ethics Steven Bradshaw,
Published by
Kudos PR
25 Jun 14 Simbec Research Limited (“Simbec”) and ORION Clinical Services Limited (“ORION”) Simbec Research
25 Jun 14 PolyPid Wins First Prize at Biomed Startup Competition PolyPid,
Published by
Kanaan Public Relations
25 Jun 14 ONYX TO INVEST IN CONTINUOUS FLOW TECHNOLOGY Onyx Scientific
24 Jun 14 Almac’s Ground-breaking AADx Gene Expression Marker Attracts Significant Commercial Interest from Pharma Almac
23 Jun 14 Shire Launches Excellence in ADHD Patient Group Awards Shire plc
23 Jun 14 ABLYNX WINS TRANSACTION OF THE YEAR AT THE 2014 EUROPEAN MEDISCIENCE AWARDS Ablynx
19 Jun 14 New Cetraben® lotion – a convenient leave-on emollient launched by Thornton & Ross Thornton & Ross,
Published by
PharmiWeb.com
18 Jun 14 UCR (Uppsala Clinical Research Center) selected Ethical eAdjudication® to Support the Clinical Endpoints Adjudication Process Ethical GmbH
17 Jun 14 Coming to Europe- Best Pharma Market Research Conference: Oct 21-22, 2014, Germany Pharma Market Research Conference
17 Jun 14 Largest Ever Head to Head Comparison of Targeted Therapy for advanced bowel cancer reports at 50th ASCO Congress Merck Serono
17 Jun 14 Merck Millipore Launches Simplicon™ RNA Reprogramming Technology for Efficient Generation of Virus-Free iPSCs Merck Millipore,
Published by
PharmiWeb.com
17 Jun 14 New one-year data of IDegLira shows glucose-lowering effect was maintained for people with type 2 diabetes Novo Nordisk
17 Jun 14 New phase 3 study shows efficacy and safety of Victoza® for the treatment of type 2 diabetes in adults with moderate renal impairment Novo Nordisk
17 Jun 14 Penn Pharma receives multiple awards at the BVCA Management Team Awards 2014 Penn Pharma,
Published by
Remarkable PR
17 Jun 14 Tresiba® (insulin degludec) achieves significantly lower rate of nocturnal hypoglycaemia compared to insulin glargine in type 2 diabetes Novo Nordisk,
Published by
Pegasus
16 Jun 14 Exco InTouch and AstraZeneca mHealth collaboration delivers ground-breaking approach to COPD management as part of the ‘Intelligent Pharmaceuticals’ initiative Exco InTouch
13 Jun 14 ARIAD ANNOUNCES PRELIMINARY SAFETY AND EFFICACY DATA OF PONATINIB IN PATIENTS WITH NEWLY DIAGNOSED CML FROM DISCONTINUED PHASE 3 EPIC TRIAL ARIAD
12 Jun 14 AstraZeneca in-licenses Synairgen's SNG001 as a novel immuno-modulatory therapy for viral-induced exacerbation in asthma AstraZeneca
Advertising